Highlight of potential impact of new viral genotypes of SARS-CoV-2 on vaccines and anti-viral therapeutics.
Gene Rep
; 26: 101537, 2022 Mar.
Article
in En
| MEDLINE
| ID: mdl-35128175
ACE2, Angiotensin-converting enzyme 2; Antiviral drugs; Bioinformatics; CSSE, Center for Systems Science and Engineering; E, Envelope; FP, Fusion peptide; HR1, Heptad repeat 1; HR2, Heptad repeat 2; IC, Intracellular domain; JHU, Johns Hopkins University; M, Membrane; Mutation detection; N, Nucleocapsid; NAG, N-acetylglucosamine; NSP, Non-structural proteins; NTD, N-terminal domain; Phylogenetic analysis; RBD, Receptor-binding domain; S, Spike glycoprotein; SARS-CoV-2; SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2;; SD1, Subdomain 1; SD2, Subdomain 2; SNP, Single nucleotide polymorphism; SP, Structural proteins; TM, Transmembrane region; UTRs, Untranslated regions; Viral vaccines
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Gene Rep
Year:
2022
Document type:
Article
Affiliation country:
Iran
Country of publication:
United States